Quick summary

Kudzu Flower (Pueraria thomsonii) is a traditional medicinal and edible plant valued for its isoflavonoid content, including puerarin, daidzein, and genistein. It has been studied mainly within the context of traditional Chinese medicine (TCM) for its potential benefits in metabolic disorders, particularly type 2 diabetes mellitus and diabetic nephropathy. Clinical evidence specifically on Kudzu Flower is limited; most human data involve products containing it or its close relative Pueraria lobata. More rigorous clinical research is needed to confirm its efficacy and safety.

What is it

Kudzu Flower is derived from the plant species Pueraria thomsonii, a member of the legume family. It is traditionally used as both a medicinal herb and a food source in East Asia. The flower contains several bioactive isoflavonoids, such as puerarin, daidzein, and genistein, which are believed to contribute to its biological activity.

Traditional uses

In traditional Chinese medicine, Kudzu Flower has been used mainly to support metabolic health. It is commonly included in herbal formulations aimed at managing symptoms related to type 2 diabetes and diabetic nephropathy. It is also traditionally valued for its potential benefits on vascular and cardiovascular conditions.

Active compounds

  • Puerarin – an isoflavonoid with anti-inflammatory and vascular effects
  • Daidzein – a phytoestrogen isoflavone
  • Genistein – another well-studied isoflavonoid with antioxidant properties

Potential benefits with evidence levels

Evidence Level 1 (Strongest available)

  • Diabetic nephropathy (adjunctive treatment): A meta-analysis of 13 randomized controlled trials (RCTs) involving 1,333 patients found that Jinlida granules containing Pueraria thomsonii improved renal function markers and glucose and lipid metabolism parameters when used as adjunct treatment. Safety data remain inconclusive. (Dai B et al. 2026)

Evidence Level 2 (Moderate)

  • Type 2 diabetes mellitus and metabolic disorders: Reviews suggest polyphenols and isoflavonoids from Pueraria species may improve insulin sensitivity, glucose metabolism, and modulate inflammation. Clinical and preclinical studies support these potential benefits, though formulations containing multiple compounds limit isolated conclusions for P. thomsonii.
    (Martiniakova M et al. 2025,
    Wang M et al. 2025,
    Li J et al. 2019)

Evidence Level 3 (Limited)

  • Cardiovascular health: Experimental studies on puerarin indicate anti-inflammatory and anti-proliferative effects on vascular smooth muscle cells relevant to atherosclerosis models. Translation to clinical benefit remains unconfirmed. (Li J et al. 2023)

Insufficient evidence

  • Hair loss: While herbal treatments for hair loss have been reviewed, no specific clinical evidence supports the use of Kudzu Flower or Pueraria thomsonii for this condition. (Allam AT et al. 2025)

Side effects

No consistent or serious adverse effects directly attributable to Kudzu Flower or Pueraria thomsonii have been reported in the available clinical studies. However, data are limited, and definitive safety conclusions cannot be made.

Drug interactions

No specific information on drug interactions involving Kudzu Flower or Pueraria thomsonii has been identified from current evidence.

Who should avoid it

No specific contraindications for Kudzu Flower or Pueraria thomsonii have been described in the literature. Due to lack of safety data, use during pregnancy and breastfeeding is not recommended without professional medical advice.

Evidence limitations

Most clinical research on Kudzu Flower involves compound herbal formulations or multi-ingredient products, making it difficult to isolate the effects of Pueraria thomsonii. Many trials have methodological limitations, such as small sample sizes, heterogeneity in interventions and outcomes, potential bias, and lack of placebo controls. High-quality, randomized, double-blind, placebo-controlled studies on Kudzu Flower alone are needed to better establish efficacy and safety.

References

  • Dai B, Chen Y, Xiao Y, et al. Efficacy and safety of Jinlida granules as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2026; PMID: 41767388. Link
  • Martiniakova M, Sarocka A, Penzes N, et al. Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus. Int J Mol Sci. 2025; PMID: 39861406. Link
  • Wang M, Yang Q, Li Y, et al. Therapeutic potential of traditional Chinese medicine and mechanisms for the treatment of type 2 diabetes mellitus. China Med. 2025; PMID: 41044789. Link
  • Li J, Li Y, Yuan X, et al. The effective constituent puerarin, from Pueraria lobata, inhibits the proliferation and inflammation of vascular smooth muscle in atherosclerosis through the miR-29b-3p/IGF1 pathway. Phytomedicine. 2023; PMID: 36537316. Link
  • Allam AT, El-Shiekh RA, El-Dessouki AM, et al. Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials. Pharmacol Rep. 2025; PMID: 40536553. Link

Last reviewed

June 2024

Disclaimer

This information is provided for educational purposes only and is not intended as medical advice. Herb use should be discussed with a qualified healthcare professional, especially if you are pregnant, breastfeeding, taking medications, or have a medical condition. The efficacy and safety of Kudzu Flower have not been fully established, and more research is needed.